MyFinsight
Home
Blog
About
Contact
Download
Download image
Comprehensive loss
-$111,472K
(-65.15%↓ Y/Y)
Unrealized gain on
available-for-sale securities, net
$2,153K
(43.72%↑ Y/Y)
Interest income
$44,042K
(47.53%↑ Y/Y)
Net loss
-$113,625K
(-64.69%↓ Y/Y)
Total other income
$44,042K
(47.53%↑ Y/Y)
Loss from operations
-$157,667K
(-59.51%↓ Y/Y)
Collaboration revenue
$10,000K
(-5.55%↓ Y/Y)
Total operating
expenses
$167,667K
(53.21%↑ Y/Y)
Research and development
$125,896K
(84.09%↑ Y/Y)
General and
administrative
$41,771K
(1.76%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Janux Therapeutics, Inc. (JANX)
Janux Therapeutics, Inc. (JANX)